Spironolactone
Product Images NDC 51655-861

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 51655-861). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655-861-26 (51655 861 26 Rev A 02 23)

51655-861-26 (51655 861 26   Rev A 02 23)
This is a medication for Spironolactone which is available in the form of Tablets with each tablet containing 50 mg of Spironolactone. The medication is a prescription-only drug, and it is recommended to follow the dosage information provided in the package insert. The tablets should be stored at a controlled room temperature, i.e., 20° - 25°C (68° - 77°F), and they should be kept away from children in the original container. The tablets have been repackaged by Northwind Pharmaceutical from Zydus Pharmaceuticals (USA) Inc., and each film-coated tablet contains 50 mg of Spironolactone, USP. The package also contains other details such as GTIN number, LOT number, and expiration date.*
FDA Label Image

Image (B9a028ee 5720 4b9e A625 F7130aafd084 01)

FDA Label Image

Image (B9a028ee 5720 4b9e A625 F7130aafd084 02)

Image (B9a028ee 5720 4b9e A625 F7130aafd084 02)
This is a comparison of two treatments, Spironolactone and Placebo, on a sample size of 822 and 841 respectively. The Log-rank p-value is less than 0.001, indicating that there is a statistically significant difference between the two treatments. The chart appears to display the progression of the treatments over 42 months.*
FDA Label Image

Image (B9a028ee 5720 4b9e A625 F7130aafd084 03)

Image (B9a028ee 5720 4b9e A625 F7130aafd084 03)
This is a table of clinical data that appears to pertain to a medical study. It includes subgroup groupings regarding age, sex, race, heart failure, NYHA, diabetes, and various drugs. It also includes numerical values for serum creatinine, creatinine clearance rate, potassium, and left ventricular ejection fraction. Additionally, it has a chart comparing the efficacy of spironolactone versus a placebo.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.